Multisystem inflammatory syndrome in children in Canada

This article provides a summary of the epidemiology of multisystem inflammatory syndrome in children (MIS-C) cases reported nationally in Canada by provincial and territorial health authorities. Multisystem inflammatory syndrome in children is a post-viral inflammatory syndrome that temporally follo...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Meghan Laverty, Marina Salvadori, Susan G Squires, May Ahmed, Lisa Eisenbeis, Santina Lee, Annick Des Cormiers, Y Anita Li
Formato:	article
Lenguaje:	EN FR
Publicado:	Public Health Agency of Canada 2021
Materias:	inflammatory syndrome covid-19 children’s health surveillance mis-c Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/bb17bc53b2ae4fef944e7e2b7244080c
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:bb17bc53b2ae4fef944e7e2b7244080c
record_format	dspace
spelling	oai:doaj.org-article:bb17bc53b2ae4fef944e7e2b7244080c2021-11-18T19:42:15ZMultisystem inflammatory syndrome in children in Canada10.14745/ccdr.v47i11a031481-8531https://doaj.org/article/bb17bc53b2ae4fef944e7e2b7244080c2021-11-01T00:00:00Zhttps://www.canada.ca/en/public-health/services/reports-publications/canada-communicable-disease-report-ccdr/monthly-issue/2021-47/issue-11-november-2021/multisystem-inflammatory-syndrome-children-canada.htmlhttps://doaj.org/toc/1481-8531This article provides a summary of the epidemiology of multisystem inflammatory syndrome in children (MIS-C) cases reported nationally in Canada by provincial and territorial health authorities. Multisystem inflammatory syndrome in children is a post-viral inflammatory syndrome that temporally follows coronavirus disease 2019 (COVID-19). Symptoms may include fever, abdominal pain, vomiting, diarrhea, skin rash and other signs of inflammation. In Canada, MIS-C is rare, with 269 cases reported to the Public Health Agency of Canada between March 11, 2020 and October 2, 2021. One hundred forty-two (53%) of these cases were lab-confirmed COVID-19 cases or epidemiologically-linked with COVID-19 cases. Cases have been reported in infants as young as one week to youth as old as 18 years, with a median age of six years. Cases were more likely to occur in males than females (58% vs 42%, respectively; p=0.006). Almost all MIS-C cases (99%) required hospitalization and 36% required intensive care unit admission. No deaths have been reported to date. The time trend of MIS-C aligns with the incidence rate time trend of COVID-19 reported in children, with a two to six-week lag.Meghan LavertyMarina SalvadoriSusan G SquiresMay AhmedLisa EisenbeisSantina LeeAnnick Des CormiersY Anita LiPublic Health Agency of Canadaarticleinflammatory syndromecovid-19children’s healthsurveillancemis-cInfectious and parasitic diseasesRC109-216ENFRCanada Communicable Disease Report , Vol 47, Iss 11, Pp 461-465 (2021)
institution	DOAJ
collection	DOAJ
language	EN FR
topic	inflammatory syndrome covid-19 children’s health surveillance mis-c Infectious and parasitic diseases RC109-216
spellingShingle	inflammatory syndrome covid-19 children’s health surveillance mis-c Infectious and parasitic diseases RC109-216 Meghan Laverty Marina Salvadori Susan G Squires May Ahmed Lisa Eisenbeis Santina Lee Annick Des Cormiers Y Anita Li Multisystem inflammatory syndrome in children in Canada
description	This article provides a summary of the epidemiology of multisystem inflammatory syndrome in children (MIS-C) cases reported nationally in Canada by provincial and territorial health authorities. Multisystem inflammatory syndrome in children is a post-viral inflammatory syndrome that temporally follows coronavirus disease 2019 (COVID-19). Symptoms may include fever, abdominal pain, vomiting, diarrhea, skin rash and other signs of inflammation. In Canada, MIS-C is rare, with 269 cases reported to the Public Health Agency of Canada between March 11, 2020 and October 2, 2021. One hundred forty-two (53%) of these cases were lab-confirmed COVID-19 cases or epidemiologically-linked with COVID-19 cases. Cases have been reported in infants as young as one week to youth as old as 18 years, with a median age of six years. Cases were more likely to occur in males than females (58% vs 42%, respectively; p=0.006). Almost all MIS-C cases (99%) required hospitalization and 36% required intensive care unit admission. No deaths have been reported to date. The time trend of MIS-C aligns with the incidence rate time trend of COVID-19 reported in children, with a two to six-week lag.
format	article
author	Meghan Laverty Marina Salvadori Susan G Squires May Ahmed Lisa Eisenbeis Santina Lee Annick Des Cormiers Y Anita Li
author_facet	Meghan Laverty Marina Salvadori Susan G Squires May Ahmed Lisa Eisenbeis Santina Lee Annick Des Cormiers Y Anita Li
author_sort	Meghan Laverty
title	Multisystem inflammatory syndrome in children in Canada
title_short	Multisystem inflammatory syndrome in children in Canada
title_full	Multisystem inflammatory syndrome in children in Canada
title_fullStr	Multisystem inflammatory syndrome in children in Canada
title_full_unstemmed	Multisystem inflammatory syndrome in children in Canada
title_sort	multisystem inflammatory syndrome in children in canada
publisher	Public Health Agency of Canada
publishDate	2021
url	https://doaj.org/article/bb17bc53b2ae4fef944e7e2b7244080c
work_keys_str_mv	AT meghanlaverty multisysteminflammatorysyndromeinchildrenincanada AT marinasalvadori multisysteminflammatorysyndromeinchildrenincanada AT susangsquires multisysteminflammatorysyndromeinchildrenincanada AT mayahmed multisysteminflammatorysyndromeinchildrenincanada AT lisaeisenbeis multisysteminflammatorysyndromeinchildrenincanada AT santinalee multisysteminflammatorysyndromeinchildrenincanada AT annickdescormiers multisysteminflammatorysyndromeinchildrenincanada AT yanitali multisysteminflammatorysyndromeinchildrenincanada
_version_	1718420749865189376

Multisystem inflammatory syndrome in children in Canada

Ejemplares similares